ReviewMolecular therapy. Nucleic acids2025

Tailored antisense oligonucleotides for ultrarare CNS diseases: An experience-based best practice framework for individual patient evaluation.

Rebecca Schüle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.